Portal de investigação
Growth Factor-Free Vascularization of Marine-Origin Collagen Sponges Using Cryopreserved Stromal Vascular Fractions from Human Adipose Tissue
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Freitas-Ribeiro, S
- Diogo, GS
- Oliveira, C
- Martins, A
- Silva, TH
- Jarnalo, M
- Reis, RL
- Pirraco, RP
Unidades de investigação
Abstract
The successful integration of transplanted three-dimensional tissue engineering (TE) constructs depends greatly on their rapid vascularization. Therefore, it is essential to address this vascularization issue in the initial design of constructs for perfused tissues. Two of the most important variables in this regard are scaffold composition and cell sourcing. Collagens with marine origins overcome some issues associated with mammal-derived collagen while maintaining their advantages in terms of biocompatibility. Concurrently, the freshly isolated stromal vascular fraction (SVF) of adipose tissue has been proposed as an advantageous cell fraction for vascularization purposes due to its highly angiogenic properties, allowing extrinsic angiogenic growth factor-free vascularization strategies for TE applications. In this study, we aimed at understanding whether marine collagen 3D matrices could support cryopreserved human SVF in maintaining intrinsic angiogenic properties observed for fresh SVF. For this, cryopreserved human SVF was seeded on blue shark collagen sponges and cultured up to 7 days in a basal medium. The secretome profile of several angiogenesis-related factors was studied throughout culture times and correlated with the expression pattern of CD31 and CD146, which showed the formation of a prevascular network. Upon in ovo implantation, increased vessel recruitment was observed in prevascularized sponges when compared with sponges without SVF cells. Immunohistochemistry for CD31 demonstrated the improved integration of prevascularized sponges within chick chorioalantoic membrane (CAM) tissues, while in situ hybridization showed human cells lining blood vessels. These results demonstrate the potential of using cryopreserved SVF combined with marine collagen as a streamlined approach to improve the vascularization of TE constructs.
Dados da publicação
- ISSN/ISSNe:
- 1660-3397, 1660-3397
- Tipo:
- Article
- Páginas:
- 623-
- DOI:
- 10.3390/md20100623
- Link para outro recurso:
- www.scopus.com
Marine Drugs Multidisciplinary Digital Publishing Institute (MDPI)
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- stromal vascular fraction; vascularization; blue shark skin collagen; 3D constructs
Financiamento
Proyectos asociados
Tissue Engineering in Plastic Surgery - What Has Been Done
Investigador Principal: Ricardo José Moreira Horta Oliveira
Estudo Clínico Académico (Plastic Surgery) . 2020
Breast Implant-Associated Anaplastic Large Cell Lymphoma - the epidemiological profile in Portugal: a cross-sectional study
Investigador Principal: Ricardo José Moreira Horta Oliveira
Estudo Clínico Académico (Breast Implan) . 2020
The efficacy of combined adjuvant radiotherapy with surgical excision in the treatment of keloids.
Investigador Principal: Ricardo José Moreira Horta Oliveira
Ensaio Clínico Académico (Keloids) . 2020
The Relation between Human Characteristics with the Angiogenic and Proliferative Potential of the Stromal Vascular Cells obtained from Subcutaneous Adipose Tissue
Investigador Principal: Ricardo José Moreira Horta Oliveira
Estudo Clínico Académico . 2021
Spontaneous keloids: a rare entity
Investigador Principal: Ricardo José Moreira Horta Oliveira
Estudo Clínico Académico . 2022
A ruler for abdominoplasty preoperative markings: the potential of best scar symmetry
Investigador Principal: Ricardo José Moreira Horta Oliveira
Estudo Clínico Académico . 2020
Citar a publicação
Freitas S,Diogo GS,Oliveira C,Martins A,Silva TH,Jarnalo M,Horta R,Reis RL,Pirraco RP. Growth Factor-Free Vascularization of Marine-Origin Collagen Sponges Using Cryopreserved Stromal Vascular Fractions from Human Adipose Tissue. Mar. Drugs. 2022. 20. (10):p. 623-623. IF:5,400. (1).
